Showing 321 - 340 results of 21,342 for search '(( significantly reported decrease ) OR ( significant decrease decrease ))', query time: 0.49s Refine Results
  1. 321

    Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae by Ziyuan Zhao (2889005)

    Published 2025
    “…Clinical evaluation showed 100% concordance with qPCR for <i>Ng</i> identification and Sanger sequencing for FC428 strain tracking. For predicting decreased-susceptibility strains with A501 mutations, MIRCA achieved 98.33% agreement with Sanger sequencing. …”
  2. 322
  3. 323
  4. 324
  5. 325
  6. 326
  7. 327
  8. 328

    Mechlorethamine gel causes epithelium thinning, epithelium-stroma separation, and decreased total stroma cell count. by Ana M. Sandoval-Castellanos (11611315)

    Published 2025
    “…<p>A) Epithelium thickness decreased, and B) the percentage of epithelium-stroma separation increased after NM exposure. …”
  9. 329
  10. 330
  11. 331
  12. 332

    RipU<sup>K60</sup> decreases microtubule abundance at 48 hours post infiltration. by Rachel Hiles (20477573)

    Published 2024
    “…(B) Heterologous expression of RipU<sup>K60</sup> significantly decreased microtubule number compared to controls at 48 hpi in <i>N</i>. …”
  13. 333
  14. 334
  15. 335
  16. 336
  17. 337
  18. 338

    Data Sheet 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

    Published 2025
    “…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  19. 339

    Data Sheet 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

    Published 2025
    “…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  20. 340

    Data Sheet 3_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

    Published 2025
    “…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”